2. Post-translational modification of Polypeptide
Protein folding
Proteolytic cleavage Intein splicing
Covalent modification
Different structures
Insulin, Zymogens
Inteins removed & Exteins spliced
a. Phosphorylation
b. Hydroxylation
c. Glycosylation
d. Carboxylation
e. Ubiquitylation
3. Amino terminal and carboxyl terminal
modifications
1st residue- N- formylmethionine (bacteria) or
Met (eukaryotes)
Formyl group and amino terminal residues is
mostly removed
50% eukaryotic proteins- NH3 group of amino
terminal residue is N-acetylated
Carboxyl terminal also may be modified
15-30 residues at the amino-terminal act as
signal sequences to direct a protein to its
target– later they are removed
4. Modifications of individualAA residues
Phosphorylation- -OH groups of Ser,Thr ,Tyr are
enzymatically phosphorylated by ATP– adds
negative charge to the protein
Casein binds to Ca+2 due to this negative charge due
to phosphoserine groups
Phosphorylation and dephosphorylation regulate
many enzymes and proteins
Carboxylation - γ- carboxylation of Prothrombin-
requiresVitamin K
Glycosylation - N-linked oligosaccharides (attached
to Asn) and O- linked oligosaccharides (Ser/Thr
residues)
Isoprenylation - thioether bond formed between Cys
and isoprene
5. Additionof prosthetic groups
Prosthetic groups bound to proteins by
covalent groups
Hb / Cyt C- Heme group
Biotin- Acetyl CoA-carboxylase
7. Inhibitors ofTranslation
A. Reversible inhibitor
a.Tetracyclin– Binds to 30s ribosome
↓
Inhibit attachment of aminoacyl tRNA to the A site
(bacteriostatic)
b. Chloramphenicol– Inhibits peptidyl
transferase- prevents elongation of peptide
chain
c. Erythromycin & Clindamycin– Prevent
translocation by binding to 50s subunit of
bacterial ribosome
9. C. Inhibitors in mammals
1. Puromycin– Structural analogue of tyrosinyl t-
RNA
2. Cycloheximide– Inhibits peptidyl transferase
3. Diphtheria toxin—Inactivation of EF-2 by
attachment of ADP to EF-2
4. Ricin– Inactivates 28s rRNA
12. For more ppt onMedicalBiochemistrypleasevisit
www.vpacharya.com
Hinweis der Redaktion
Protein splicing is an intramolecular reaction of a particular protein in which an internal protein segment (called an intein) is removed from a precursor protein with a ligation of C-terminal and N-terminal external proteins (called exteins) on both sides. The splicing junction of the precursor protein is mainly a cysteine or a serine, which are amino acids containing a nucleophilic side chain. The protein splicing reactions which are known now do not require exogenous cofactors or energy sources such as adenosine triphosphate (ATP) or guanosine triphosphate (GTP). Normally, splicing is associated only with pre-mRNA splicing. This precursor protein contains three segments—an N-extein followed by the intein followed by a C-extein. After splicing has taken place, the resulting protein contains the N-extein linked to the C-extein; this splicing product is also termed an extein.